Lifax Pharma Private Limited
About Lifax Pharma Private Limited
Data last updated:
Lifax Pharma Private Limited is a private limited company based in Kollam, Kerala, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 11 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U85100KL2019PTC060715. Its GSTIN is 32AAECL0998F1ZJ (Kerala).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohamed Abdul Rahim Pathiya Parambath Aboobaker and Akzer Thaha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mc Xvii /2995 To 3001 District Hospital Road, Kollam, Kerala, India – 691001.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.03 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.07 Cr (net margin -16.1%) and EBITDA of -₹1.82 Cr (EBITDA margin -9.6%).
Company details
Contact details
Lifax Pharma Private Limited's registered office is in Kollam, Kerala. Its e-mail address is in the company report.
- Email
- Registered AddressMc Xvii /2995 To 3001 District Hospital Road, Kollam, Kerala, India – 691001
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Lifax Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lifax Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Lifax Pharma Private Limited, buy the company report.
Financials of Lifax Pharma Private Limited
FY 2025 filings availableLifax Pharma Private Limited reported revenue of ₹19.03 Cr (up 324% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 324% in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.82 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.6% | ||||
| Net Profit Margin | -16.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lifax Pharma Private Limited, buy the company report.
Board of directors of Lifax Pharma Private Limited
Lifax Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohamed Abdul Rahim Pathiya Parambath Aboobaker Also directs: V-Care Town Medicals LLP, Medseven Facilities Management LLP, Vcarepmna Medicals LLP and 3 more | Director | 31 Mar 2025 | 1 Years 6 Months | Current |
| Akzer Thaha Also directs: Vcarealuva Medicals LLP | Director | 31 Mar 2025 | 1 Years 6 Months | Current |
| Jabir Ekkaden Also directs: Docone Healthcare LLP | Director | 31 Mar 2025 | 1 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Lifax Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lifax Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lifax Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAECL0998F1ZJ | Kerala | Active | 27 Feb 2021 |
To see the full GST registrations and return filing status of Lifax Pharma Private Limited, buy the company report.
Recent activity
Lifax Pharma Private Limited has 7 board changes on record since 2019: 5 appointments and 2 cessations. The latest: Abdul Nazzar ceased to be Director on 31 Mar 2025.
Frequently asked questions
Lifax Pharma is an active private limited company based in Kollam, Kerala, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 11 December 2019 (7+ years old) and is registered under CIN U85100KL2019PTC060715.
Lifax Pharma has 3 current directors:
- Mohamed Abdul Rahim Pathiya Parambath Aboobaker - Director
- Akzer Thaha - Director
- Jabir Ekkaden - Director
The latest financial statements of Lifax Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Lifax Pharma is 32AAECL0998F1ZJ, registered in Kerala.
The CIN (Corporate Identification Number) of Lifax Pharma is U85100KL2019PTC060715. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lifax Pharma was incorporated on 11 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ernakulam.
Abdul Nazzar ceased to be Director on 31 Mar 2025. Abdulvahid Abdulrahuman ceased to be Director on 31 Mar 2025. Akzer Thaha was appointed as Director on 31 Mar 2025. Lifax Pharma has 7 board changes on record in total.
The registered office of Lifax Pharma is at Mc Xvii 2995 To 3001 District Hospital Road, Kollam, Kerala, India – 691001.
Lifax Pharma operates in the healthcare industry, in the medical and laboratory equipment segment.
Lifax Pharma can be reached at its registered office: Mc Xvii 2995 To 3001 District Hospital Road, Kollam, Kerala, India – 691001.